GSK PLC's ticker is and the CUSIP is 37733W204. A total of 784 filers reported holding GSK PLC in Q1 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,331,250 | -3.4% | 285,000 | -5.0% | 0.16% | +1.9% |
| Q2 2023 | $10,692,000 | -90.7% | 300,000 | -90.7% | 0.16% | -90.7% |
| Q1 2023 | $115,136,880 | +7.2% | 3,236,000 | +5.9% | 1.66% | -11.5% |
| Q4 2022 | $107,387,840 | +1.4% | 3,056,000 | -15.1% | 1.87% | +1.9% |
| Q3 2022 | $105,948,000 | – | 3,600,000 | – | 1.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 12,444,460 | $451,112 | 41.96% |
| Eversept Partners, LP | 3,259,342 | $118,151,148 | 10.00% |
| Sio Capital Management, LLC | 509,000 | $18,451,250 | 5.71% |
| Callodine Capital Management, LP | 475,000 | $17,218,750 | 4.80% |
| EQUITY INVESTMENT CORP | 3,277,362 | $118,804,373 | 3.70% |
| Clean Yield Group | 207,739 | $7,802,677 | 3.46% |
| Robinson Value Management, Ltd. | 128,116 | $4,644,205 | 3.46% |
| Camber Capital Management LP | 2,850,000 | $103,313 | 3.40% |
| Hillman Capital Management, Inc. | 232,864 | $8,441,320 | 3.25% |
| Soleus Capital Management, L.P. | 943,000 | $34,183,750 | 3.15% |